Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial

Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial

The prospective PRIME trial applied real-time, objective imaging biomarkers to determine individualized retreatment needs with intravitreal aflibercept injections (IAI) among eyes with diabetic retinopathy (DR). 40 eyes with nonproliferative or proliferative DR without diabetic macular edema receive...

Full description

Bibliographic Details
Main Authors: Hannah J. Yu, Justis P. Ehlers, Duriye Damla Sevgi, Margaret O’Connell, Jamie L. Reese, Sunil K. Srivastava, Charles C. Wykoff
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Personalized Medicine
Subjects:
diabetic retinopathy
anti-vascular endothelial growth factor
diabetic retinopathy severity scale
panretinal leakage index
Online Access:https://www.mdpi.com/2075-4426/11/9/885

Internet

https://www.mdpi.com/2075-4426/11/9/885

Similar Items